{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T22:37:51Z","timestamp":1777675071496,"version":"3.51.4"},"reference-count":134,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:p>In 2020 nearly 12 million people worldwide suffered a stroke, and acute ischemic stroke (AIS) is the most frequent stroke subtype, accounting for approximately 65% of total stroke incidence. Therefore, primary prevention, including non-traditional risk factors, should be recognized as a major public health priority. Research has shown that autoimmune diseases associated with chronic systemic inflammation, such as psoriasis, are commonly linked to AIS incidence. Psoriasis is a chronic autoimmune erythematous-squamous disease that primarily affects the skin, nails, and joints. Psoriasis is known to be a systemic inflammatory condition affecting multiple organs. Patients with psoriasis are at a higher risk of stroke than the general population, and a more severe disease course can increase this risk by up to 44%. One possible explanation for this phenomenon is that chronic systemic inflammation is associated with endothelial dysfunction and atherosclerotic plaque development. On the other hand, patients with psoriasis have an increased prevalence of traditional cardiovascular risk factors, including metabolic syndrome. This narrative review synthesizes the scientific literature to provide a comprehensive overview of the current understanding of the association between psoriasis and AIS.<\/jats:p>","DOI":"10.3389\/fneur.2025.1599978","type":"journal-article","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:10:40Z","timestamp":1749787840000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Psoriasis: an emerging risk factor for ischemic stroke?"],"prefix":"10.3389","volume":"16","author":[{"given":"Piotr","family":"Olejnik","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaja","family":"Kasare\u0142\u0142o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Podkowi\u0144ska-Polak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aleksandra","family":"Golenia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,13]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1474-4422(19)30034-1","article-title":"Global, regional, and national burden of stroke, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"18","author":"Johnson","year":"2019","journal-title":"Lancet Neurol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"100527","DOI":"10.1016\/j.ejro.2023.100527","article-title":"Epidemiology, organization, diagnosis and treatment of acute ischemic stroke","volume":"11","author":"Capirossi","year":"2023","journal-title":"Eur J Radiol Open"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e036142","DOI":"10.1161\/JAHA.124.036142","article-title":"Projections of the stroke burden at the global, regional, and National Levels up to 2050 based on the global burden of disease study 2021","volume":"13","author":"Cheng","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.jacc.2019.12.072","article-title":"Primary and secondary prevention of ischemic stroke and cerebral hemorrhage","volume":"75","author":"Diener","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2518","DOI":"10.1161\/01.STR.0000089015.51603.CC","article-title":"Inflammation and infections as risk factors for ischemic stroke","volume":"34","author":"Lindsberg","year":"2003","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1161\/STROKEAHA.119.024157","article-title":"Inflammation, autoimmunity, infection, and stroke","volume":"51","author":"Parikh","year":"2020","journal-title":"Stroke"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.4103\/2229-5178.193906","article-title":"Psoriasis: epidemiology, clinical features, co-morbidities, and clinical scoring","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"170","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja","year":"2021","journal-title":"Clin Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.3233\/IDT-230779","article-title":"Differential diagnosis of erythemato-squamous diseases using a hybrid ensemble machine learning technique","volume":"18","author":"Swain","year":"2024","journal-title":"Intell Decis Technol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"BMJ"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s13671-012-0034-6","article-title":"Risk factors for psoriasis","volume":"2","author":"Naldi","year":"2013","journal-title":"Curr Dermatol Rep"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jaut.2015.07.008","article-title":"The immunogenetics of psoriasis: A comprehensive review","volume":"64","author":"Harden","year":"2015","journal-title":"J Autoimmun"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1111\/bjd.18245","article-title":"Management of psoriasis as a systemic disease: what is the evidence?","volume":"182","author":"Korman","year":"2020","journal-title":"Br J Dermatol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1468-3083.2011.04410.x","article-title":"The concept of psoriasis as a systemic inflammation: implications for disease management","volume":"26","author":"Reich","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"101574","DOI":"10.1016\/j.ancard.2022.11.009","article-title":"Infarctus du myocarde, accident vasculaire c\u00e9r\u00e9bral et psoriasis: une revue syst\u00e9matique des \u00e9tudes observationnelles","volume":"72","author":"Correa","year":"2023","journal-title":"Ann Cardiol Angeiol (Paris)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/ejhf.113","article-title":"Psoriasis and risk of heart failure: a nationwide cohort study","volume":"16","author":"Khalid","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v17.i4.104717","article-title":"Emerging risk factors for heart failure in younger populations: a growing public health concern","volume":"17","author":"Parizad","year":"2025","journal-title":"World J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s00403-024-02999-x","article-title":"A cross-sectional study of psoriasis hospitalizations in patients with cardiovascular comorbidities in patients under 60","volume":"316","author":"Eckembrecher","year":"2024","journal-title":"Arch Dermatol Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2147\/VHRM.S464471","article-title":"Cardiovascular considerations and implications for treatment in psoriasis: an updated review","volume":"20","author":"Mehta","year":"2024","journal-title":"Vasc Health Risk Manag"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5114\/reum.2022.119043","article-title":"Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis","volume":"60","author":"Olszewski","year":"2022","journal-title":"Rheumatology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1093\/eurheartj\/ehr285","article-title":"Psoriasis and risk of atrial fibrillation and ischaemic stroke: a Danish Nationwide cohort study","volume":"33","author":"Ahlehoff","year":"2012","journal-title":"Eur Heart J"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.868277","article-title":"Psoriasis and cardiovascular diseases: an immune-mediated cross talk?","volume":"13","author":"Orlando","year":"2022","journal-title":"Front Immunol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1038\/jid.2009.112","article-title":"The risk of stroke in patients with psoriasis","volume":"129","author":"Gelfand","year":"2009","journal-title":"J Invest Dermatol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00242","article-title":"Innate lymphocytes in psoriasis","volume":"11","author":"Polese","year":"2020","journal-title":"Front Immunol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.3390\/ijms20061475","article-title":"Psoriasis pathogenesis and treatment","volume":"20","author":"Rendon","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1346-8138.2011.01483.x","article-title":"Antimicrobial peptides in the pathogenesis of psoriasis","volume":"39","author":"Morizane","year":"2012","journal-title":"J Dermatol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"9294","DOI":"10.3390\/ijms22179294","article-title":"The role of epigenetic factors in psoriasis","volume":"22","author":"Dopytalska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.3390\/ijms21041275","article-title":"Interleukin-17A and keratinocytes in psoriasis","volume":"21","author":"Furue","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1080\/15548627.2020.1725381","article-title":"Autophagy-based unconventional secretion of HMGB1 by keratinocytes plays a pivotal role in psoriatic skin inflammation","volume":"17","author":"Wang","year":"2021","journal-title":"Autophagy"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.jaci.2017.07.004","article-title":"Psoriasis pathogenesis and the development of novel targeted immune therapies","volume":"140","author":"Hawkes","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/nature05663","article-title":"Pathogenesis and therapy of psoriasis","volume":"445","author":"Lowes","year":"2007","journal-title":"Nature"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-2133.1997.01845.x","article-title":"Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis","volume":"136","author":"Creamer","year":"1997","journal-title":"Br J Dermatol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J Exp Med"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2017.07.007","article-title":"Psoriasis: a mixed autoimmune and autoinflammatory disease","volume":"49","author":"Liang","year":"2017","journal-title":"Curr Opin Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1172\/JCI118263","article-title":"Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis","volume":"96","author":"Leung","year":"1995","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1155\/MI.2005.273","article-title":"Serum levels of TNF-\u03b1, IFN-\u03b3, IL-6, IL-8, IL-12, IL-17, and IL-18 in patients with active psoriasis and correlation with disease severity","volume":"2005","author":"Arican","year":"2005","journal-title":"Mediat Inflamm"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Su\u00e1rez-Fari\u00f1as","year":"2012","journal-title":"J Invest Dermatol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"819149","DOI":"10.1155\/2015\/819149","article-title":"IL-17A, IL-22, IL-6, and IL-21 serum levels in plaque-type psoriasis in Brazilian patients","volume":"2015","author":"Oliveira","year":"2015","journal-title":"Mediat Inflamm"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2230.2009.03704.x","article-title":"Serum cytokines and growth factor levels in Japanese patients with psoriasis","volume":"35","author":"Takahashi","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/JID.2010.103","article-title":"Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions","volume":"130","author":"Davidovici","year":"2010","journal-title":"J Invest Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.gene.6364351","article-title":"Psoriasis: genetic associations and immune system changes","volume":"8","author":"Liu","year":"2007","journal-title":"Genes Immun"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J Invest Dermatol"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/bjd.12355","article-title":"Markers of systemic inflammation in psoriasis: a systematic review and meta-analysis","volume":"169","author":"Dowlatshahi","year":"2013","journal-title":"Br J Dermatol"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.berh.2021.101694","article-title":"Pathogenesis of psoriatic arthritis","volume":"35","author":"Stober","year":"2021","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3238\/arztebl.m2024.0064","article-title":"Psoriasis as a systemic disease","volume":"121","author":"Mrowietz","year":"2024","journal-title":"Dtsch Arztebl Int"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"4457","DOI":"10.3390\/ijms23084457","article-title":"Psoriasis and systemic inflammatory disorders","volume":"23","author":"Tashiro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1161\/CIRCULATIONAHA.108.827618","article-title":"Interleukin-17 and interferon-\u03b3 are produced concomitantly by human coronary artery\u2013infiltrating T cells and act synergistically on vascular smooth muscle cells","volume":"119","author":"Eid","year":"2009","journal-title":"Circulation"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.4049\/jimmunol.1000116","article-title":"A critical function of Th17 Proinflammatory cells in the development of atherosclerotic plaque in mice","volume":"185","author":"Gao","year":"2010","journal-title":"J Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"4344","DOI":"10.4049\/jimmunol.1400181","article-title":"IL-17A influences essential functions of the monocyte\/macrophage lineage and is involved in advanced murine and human atherosclerosis","volume":"193","author":"Erbel","year":"2014","journal-title":"J Immunol"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00579","article-title":"Systemic inflammation and cardiovascular comorbidity in psoriasis patients: causes and consequences","volume":"9","author":"Boehncke","year":"2018","journal-title":"Front Immunol"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2340\/0001555565258262","article-title":"Increased platelet aggregation in psoriasis","volume":"65","author":"Hayashi","year":"1985","journal-title":"Acta Derm Venereol"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood\u2013brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav Immun"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.neuroscience.2008.08.019","article-title":"Systemic infection, inflammation and acute ischemic stroke","volume":"158","author":"McColl","year":"2009","journal-title":"Neuroscience"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"4719","DOI":"10.1093\/eurheartj\/ehae557","article-title":"Systemic inflammation and health outcomes in patients receiving treatment for atherosclerotic cardiovascular disease","volume":"45","author":"Mazhar","year":"2024","journal-title":"Eur Heart J"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/2229-5178.164483","article-title":"Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis","volume":"6","author":"Vadakayil","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"ref61","first-page":"151","article-title":"Predictive ability of C-reactive protein for stroke","volume":"7","author":"Ahmadi-Ahangar","year":"2016","journal-title":"Caspian J Intern Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","article-title":"The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis","volume":"55","author":"Blauvelt","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1007\/s12035-023-03723-y","article-title":"Th17 cells and IL-17A in ischemic stroke","volume":"61","author":"Wang","year":"2024","journal-title":"Mol Neurobiol"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/ATVBAHA.114.303567","article-title":"IL-17 and Th17 cells in atherosclerosis","volume":"35","author":"Taleb","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"13043","DOI":"10.1038\/s41598-021-90684-8","article-title":"Psoriatic disease is associated with systemic inflammation, endothelial activation, and altered haemostatic function","volume":"11","author":"Visser","year":"2021","journal-title":"Sci Rep"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.2147\/JIR.S427992","article-title":"Fibrinogen is associated with clinical adverse events in patients with psoriasis and coronary artery disease","volume":"16","author":"Zhao","year":"2023","journal-title":"J Inflamm Res"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000246755","article-title":"Abnormalities of blood coagulation and fibrinolysis in psoriasis","volume":"189","author":"Marongiu","year":"1994","journal-title":"Dermatology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"e34335","DOI":"10.7759\/cureus.34335","article-title":"Association of Fibrinogen with Ischemic Stroke: A systematic review and Meta-analysis","volume":"15","author":"Prasad","year":"2023","journal-title":"Cureus"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.774808","article-title":"Cardiometabolic comorbidities in patients with psoriasis: focusing on risk, biological therapy, and pathogenesis","volume":"12","author":"Cai","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1242\/dmm.001180","article-title":"A comprehensive definition for metabolic syndrome","volume":"2","author":"Huang","year":"2009","journal-title":"Dis Model Mech"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/jcm13020492","article-title":"Multimorbidity of psoriasis: A large-scale population study of its associated comorbidities","volume":"13","author":"Almenara-Blasco","year":"2024","journal-title":"J Clin Med"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"e45409","DOI":"10.7759\/cureus.45409","article-title":"Dyslipidemia and obesity in ischemic stroke","volume":"15","author":"Gajurel","year":"2023","journal-title":"Cureus"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"786","DOI":"10.3390\/ijms23020786","article-title":"Metabolic syndrome: updates on pathophysiology and management in 2021","volume":"23","author":"Fahed","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"103577","DOI":"10.1016\/j.autrev.2024.103577","article-title":"Global prevalence of obesity in patients with psoriasis: an analysis in the past two decades","volume":"23","author":"Wang","year":"2024","journal-title":"Autoimmun Rev"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"9","DOI":"10.5469\/neuroint.2020.00108","article-title":"Obesity and stroke: does the paradox apply for stroke?","volume":"16","author":"Qui\u00f1ones-Ossa","year":"2021","journal-title":"Neurointervention"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","article-title":"Adipokines: A link between obesity and cardiovascular disease","volume":"63","author":"Nakamura","year":"2014","journal-title":"J Cardiol"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12944-019-1115-3","article-title":"New insights into different adipokines in linking the pathophysiology of obesity and psoriasis","volume":"18","author":"Kong","year":"2019","journal-title":"Lipids Health Dis"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"6390","DOI":"10.3390\/ijms24076390","article-title":"The role of Adipokines in the pathogenesis of psoriasis","volume":"24","author":"Kie\u0142bowski","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1177\/24755303231199995","article-title":"Serum adiponectin levels as an independent marker of severity of psoriasis: A cross-sectional analysis","volume":"8","author":"Kaushik","year":"2023","journal-title":"J Psoriasis Psoriatic Arthritis"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1161\/01.ATV.0000157784.25920.a7","article-title":"Hypoadiponectinemia is associated with ischemic cerebrovascular disease","volume":"25","author":"Chen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1161\/01.STR.0000177874.29849.f0","article-title":"Plasma adiponectin levels and five-year survival after first-ever ischemic stroke","volume":"36","author":"Efstathiou","year":"2005","journal-title":"Stroke"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1111\/j.1476-5381.2011.01395.x","article-title":"Adiponectin and cardiovascular health: an update","volume":"165","author":"Hui","year":"2012","journal-title":"Br J Pharmacol"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/s12944-020-01391-8","article-title":"The role of leptin in selected skin diseases","volume":"19","author":"Dopytalska","year":"2020","journal-title":"Lipids Health Dis"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/exd.12162","article-title":"Leptin induces secretion of pro-inflammatory cytokines by human keratinocytes in vitro \u2013 a possible reason for increased severity of psoriasis in patients with a high body mass index","volume":"22","author":"Xue","year":"2013","journal-title":"Exp Dermatol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.numecd.2023.09.001","article-title":"The role of leptin in ischemic stroke and its subtypes: A Mendelian randomization study","volume":"34","author":"Dai","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4103\/jnrp.jnrp_5_18","article-title":"Role of leptin in acute ischemic stroke","volume":"9","author":"Menon","year":"2018","journal-title":"J Neurosci Rural Pract"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1080\/02688697.2019.1578862","article-title":"The emerging role of leptin, adiponectin and Visfatin in ischemic\/hemorrhagic stroke","volume":"33","author":"Ilhan","year":"2019","journal-title":"Br J Neurosurg"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1177\/03000605211002381","article-title":"Association between serum visfatin levels and psoriasis and their correlation with disease severity: a meta-analysis","volume":"49","author":"Zou","year":"2021","journal-title":"J Int Med Res"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"e25184","DOI":"10.1097\/MD.0000000000025184","article-title":"Association of serum vaspin, apelin, and visfatin levels and stroke risk in a Chinese case-control study","volume":"100","author":"Yu","year":"2021","journal-title":"Medicine"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13684","article-title":"Adipokines and stroke: A systematic review and meta-analysis of disease risk and patient outcomes","volume":"25","author":"Agbaedeng","year":"2024","journal-title":"Obes Rev"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1080\/08820139.2023.2288836","article-title":"Resistin \u2013 A plausible therapeutic target in the pathogenesis of psoriasis","volume":"53","author":"Srikanth","year":"2024","journal-title":"Immunol Investig"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"2397","DOI":"10.3390\/ijms23042397","article-title":"Diabetes and ischemic stroke: an old and new relationship an overview of the close interaction between these diseases","volume":"23","author":"Maida","year":"2022","journal-title":"Int J Mol Sci"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","article-title":"Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes","volume":"351","author":"Chen","year":"2016","journal-title":"Am J Med Sci"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.2147\/DMSO.S273147","article-title":"Diabetes and psoriasis: different sides of the same prism","volume":"13","author":"Abramczyk","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/2013.jamadermatol.406","article-title":"Psoriasis and the risk of diabetes mellitus","volume":"149","author":"Armstrong","year":"2013","journal-title":"JAMA Dermatol"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"19313","DOI":"10.1038\/s41598-023-46795-5","article-title":"Exploring the molecular mechanism underlying the psoriasis and T2D by using microarray data analysis","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.605691","article-title":"Psoriasis and diabetes, a dangerous association: evaluation of insulin resistance, lipid abnormalities, and cardiovascular risk biomarkers","volume":"8","author":"Brazzelli","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.jaad.2015.01.004","article-title":"Patients with psoriasis are insulin resistant","volume":"72","author":"Gyldenl\u00f8ve","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.3390\/jcm14041374","article-title":"The risk of metabolic dysfunction-associated Steatotic liver disease in moderate-to-severe psoriasis: A systematic review and Meta-analysis","volume":"14","author":"Untaaveesup","year":"2025","journal-title":"J Clin Med"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.17925\/EE.2024.20.2.2","article-title":"Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: a deadly synergy","volume":"20","author":"Leith","year":"2024","journal-title":"Touch Reviews in Endocrinology"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s00403-024-03688-5","article-title":"Biologic therapy for psoriasis is associated with the development of metabolic dysfunction-associated steatotic liver disease (MASLD). A study on the association of cardiometabolic conditions with psoriasis treatment","volume":"317","author":"Armijo-Borjon","year":"2025","journal-title":"Arch Dermatol Res"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-21-0007","article-title":"Two birds one stone: semaglutide is highly effective against severe psoriasis in a type 2 diabetic patient","volume":"2021","author":"Costanzo","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/RHU.0000000000001949","article-title":"Glucagon-like peptide 1 receptor agonists in patients with inflammatory arthritis or psoriasis","volume":"30","author":"Karacabeyli","year":"2024","journal-title":"JCR J Clin Rheumatol"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2147\/PTT.S485061","article-title":"Impact of GLP-1 receptor agonists on psoriasis and cardiovascular comorbidities: A narrative review","volume":"14","author":"Haran","year":"2024","journal-title":"Psoriasis: Targets and Therapy"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"3541","DOI":"10.3748\/wjg.v30.i30.3541","article-title":"Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease","volume":"30","author":"Soresi","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"5205","DOI":"10.3748\/wjg.v30.i48.5205","article-title":"GLP-1, GIP\/GLP-1, and GCGR\/GLP-1 receptor agonists: novel therapeutic agents for metabolic dysfunction-associated steatohepatitis","volume":"30","author":"Singh","year":"2024","journal-title":"World J Gastroenterol"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.3390\/cimb46070399","article-title":"Common denominator of MASLD and some non-communicable diseases","volume":"46","author":"Ferenc","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/729157","article-title":"Dyslipidemia in psoriasis: A case controlled study","volume":"2014","author":"Nakhwa","year":"2014","journal-title":"Int Sch Res Notices"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/microorganisms13010161","article-title":"Skin microbiota: mediator of interactions between metabolic disorders and cutaneous health and disease","volume":"13","author":"Kreouzi","year":"2025","journal-title":"Microorganisms"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3988\/jcn.2016.12.2.137","article-title":"Blood pressure in acute ischemic stroke","volume":"12","author":"McManus","year":"2016","journal-title":"J Clin Neurol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/HJH.0b013e32835bcce1","article-title":"The association between psoriasis and hypertension","volume":"31","author":"Armstrong","year":"2013","journal-title":"J Hypertens"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5455\/medarh.2015.69.13-15","article-title":"Psoriasis and high blood pressure","volume":"69","author":"Salihbegovic","year":"2015","journal-title":"Medical Archives"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1001\/jamadermatol.2014.2094","article-title":"Effect of psoriasis severity on hypertension control","volume":"151","author":"Takeshita","year":"2015","journal-title":"JAMA Dermatol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1111\/ced.14327","article-title":"The association of psoriasis and hypertension: focusing on anti-inflammatory therapies and immunological mechanisms","volume":"45","author":"Hu","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1161\/ATVBAHA.114.304108","article-title":"Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease","volume":"34","author":"Karbach","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"262","DOI":"10.5114\/aoms\/130392","article-title":"Role of the interleukin-17 pathway in the pathogenesis of atrial fibrillation associated with inflammation","volume":"17","author":"Yue","year":"2021","journal-title":"Arch Med Sci"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1253\/circj.CJ-12-1155","article-title":"Role of tumor necrosis factor-\u03b1 in the pathogenesis of atrial fibrosis and development of an Arrhythmogenic substrate","volume":"77","author":"Liew","year":"2013","journal-title":"Circ J"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/cvr\/cvp203","article-title":"The role of connexin40 in atrial fibrillation","volume":"84","author":"Chaldoupi","year":"2009","journal-title":"Cardiovasc Res"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"102538","DOI":"10.1016\/j.cpcardiol.2024.102538","article-title":"Association between psoriasis and atrial fibrillation: A systematic review and meta-analysis","volume":"49","author":"Jain","year":"2024","journal-title":"Curr Probl Cardiol"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1161\/CIRCULATIONAHA.117.029126","article-title":"Coronary plaque characterization in psoriasis","volume":"136","author":"Kivelevitch","year":"2017","journal-title":"Circulation"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"229","DOI":"10.4330\/wjc.v15.i5.229","article-title":"Atrial fibrillation and coronary artery disease: an integrative review focusing on therapeutic implications of this relationship","volume":"15","author":"Batta","year":"2023","journal-title":"World J Cardiol"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"9973","DOI":"10.1038\/s41598-017-10556-y","article-title":"Increased risk of atrial fibrillation and thromboembolism in patients with severe psoriasis: a Nationwide population-based study","volume":"7","author":"Rhee","year":"2017","journal-title":"Sci Rep"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.3390\/ijms18102211","article-title":"Psoriasis and cardiovascular comorbidities: focusing on severe vascular events, cardiovascular risk factors and implications for treatment","volume":"18","author":"Hu","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/pds.3890","article-title":"Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan","volume":"25","author":"Lee","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/VHRM.S54159","article-title":"Risk of stroke associated with nonsteroidal anti-inflammatory drugs","volume":"10","author":"Bavry","year":"2014","journal-title":"Vasc Health Risk Manag"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/STROKEAHA.115.012231","article-title":"Preadmission use of glucocorticoids and 30-day mortality after stroke","volume":"47","author":"Sundb\u00f8ll","year":"2016","journal-title":"Stroke"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"e646","DOI":"10.1161\/STROKEAHA.120.033272","article-title":"Drugs associated with ischemic stroke","volume":"52","author":"Marto","year":"2021","journal-title":"Stroke"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1212\/WNL.0000000000001639","article-title":"Cyclosporine in acute ischemic stroke","volume":"84","author":"Nighoghossian","year":"2015","journal-title":"Neurology"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/dth.12085","article-title":"Oral retinoids and plasma lipids","volume":"26","author":"Lilley","year":"2013","journal-title":"Dermatol Ther"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"21","DOI":"10.5853\/jos.2021.02831","article-title":"Hypertriglyceridemia: A neglected risk factor for ischemic stroke?","volume":"24","author":"Liang","year":"2022","journal-title":"J Stroke"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/jdv.12768","article-title":"Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort","volume":"29","author":"Ahlehoff","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaad.2016.07.042","article-title":"Cardiovascular event risk assessment in psoriasis patients treated with tumor necrosis factor-\u03b1 inhibitors versus methotrexate","volume":"76","author":"Wu","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s40257-015-0166-0","article-title":"IL-17 blockade in psoriasis: friend or foe in cardiovascular risk?","volume":"17","author":"Torres","year":"2016","journal-title":"Am J Clin Dermatol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jaad.2013.09.020","article-title":"From the medical board of the National Psoriasis Foundation: the risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies","volume":"70","author":"J","year":"2014","journal-title":"J Am Acad Dermatol"}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1599978\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T04:10:41Z","timestamp":1749787841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2025.1599978\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":134,"alternative-id":["10.3389\/fneur.2025.1599978"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2025.1599978","relation":{},"ISSN":["1664-2295"],"issn-type":[{"value":"1664-2295","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,13]]},"article-number":"1599978"}}